Gladius Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-727
| Closed | -$39.4K | – | 263 |
|
|
2024
Q1 | $39.4K | Buy |
+727
| New | +$39.4K | 0.01% | 162 |
|
|
2022
Q3 | – | Sell |
-1,404
| Closed | -$109K | – | 322 |
|
|
2022
Q2 | $109K | Sell |
1,404
-7,218
| -84% | -$560K | 0.01% | 130 |
|
|
2022
Q1 | $630K | Buy |
8,622
+6,219
| +259% | +$454K | 0.05% | 38 |
|
|
2021
Q4 | $150K | Buy |
+2,403
| New | +$150K | 0.01% | 119 |
|
|
2021
Q2 | – | Sell |
-1,186
| Closed | -$75K | – | 42 |
|
|
2021
Q1 | $75K | Buy |
+1,186
| New | +$75K | ﹤0.01% | 31 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 52 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 74 |
|